Lv2
118 积分 2024-04-16 加入
Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients
6天前
已完结
Systematic Reviews and Meta-Analyses of the Use of Tocilizumab inTreating Central Nervous Diseases
20天前
已完结
French NOMADMUS Cohort Overview
26天前
已完结
French NOMADMUS Cohort Overview
27天前
已完结
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the Republic of Korea
1个月前
已完结
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
1个月前
已关闭
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
1个月前
已关闭
Efficacy of a fixed-interval, body surface area-adjusted rituximab regimen in Singaporean patients with CNS inflammatory demyelinating diseases
1个月前
已关闭
Optimal strategies for treatment discontinuation in MOG antibody-associated disease
1个月前
已完结
皖公网安备34019202002308
